Dr. Mehmet Oz, CMS Administrator, emphasizes the need to lower healthcare costs while ensuring Americans remain active and productive. Speaking with Fox News Digital at the Great American State Fair in Washington, D.C., Oz shares insights gained from his time in the Trump administration.
The Cost of Poor Healthcare
According to Oz, the high expense in healthcare often comes from substandard care. Paying unqualified individuals leads to additional costs as errors need rectifying. This creates further issues downstream, adding more expenses.
Focusing on Quality
Oz stresses the importance of quality care at the Centers for Medicare & Medicaid Services. His aim is not only to prevent diseases but also to promote healthy habits. Implementing value-based healthcare interactions is key.
Oz advocates for innovative technologies in healthcare, like AI, which, if used properly, can enhance care delivery. By integrating new screening techniques and medications, patients can better manage their health.
Encouraging Wellness Visits
Each Medicare beneficiary is entitled to a free annual wellness exam, yet less than half utilize this benefit. Avoiding these check-ups means potential health issues could go unnoticed, leading to bigger, costly problems.
Oz remarks that ignoring health issues is misguided. In healthcare, awareness is crucial to prevent future complications.
The Economic Impact
Oz projects that healthier Americans could significantly benefit the nation’s economy. Improved vitality can encourage older individuals to work longer, potentially adding $1 trillion in value to the GDP.
Most Americans wish to remain productive as they age but often feel physically diminished. Oz suggests focusing on health will not only lower expenditures but increase revenue by fostering a healthier workforce.
Lifestyle reporter Angelica Stabile covered this interview for Fox News Digital.

New Insights into Suicide Prevention Strategies
Philadelphia Reports Measles Exposures at Airport and Hospital
Legal Challenges Arise Over GLP-1 Receptor Agonists and Vision Loss Risks
States Move to Restrict Tianeptine Amid Growing Concerns
Potential Changes in Medicare Reimbursement for Lab Tests
Understanding and Addressing the Complexity of Suicide